The decisions behind scientific progress

<p>In this episode of Denatured, sponsored by Cytiva, Jennifer Smith-Parker speaks to Nicolas Pivet, VP &amp; GM, Manufacturing &amp; Digital Solutions at Cytiva. In this episode, we discuss how biopharma has long invested in more data and visibility, yet many programs still face delays and scale-up surprises. The real challenge isn’t information overload—it’s building confidence in the decisions that steer scientific progress from development through commercialization.</p><p></p><p>This episode is presented in partnership with <a rel="noopener noreferrer nofollow" href="https://www.cytivalifesciences.com/en/us" target="_blank">Cytiva</a>. </p><p></p><p><b>Host</b></p><p><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/jennifersmithparker/" target="_blank">Jennifer Smith-Parker</a>, Director of Insights, BioSpace</p><p></p><p><b>Guest</b></p><p><a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/nicolas-pivet-a30b891b/" target="_blank">Nicolas Pivet,</a> VP &amp; GM, Manufacturing &amp; Digital Solutions, Cytiva</p><p></p><p></p><p><i>Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations</i></p>